REBISMART, the first electronic
injection device for the treatment
of multiple sclerosis, has been
approved for use in Australia and
will be available on the
Pharmaceutical Benefits Scheme
from 01 May.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Apr 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Apr 10
CHEMIST Warehouse chief operating officer Mario Tascone (pictured above centre) presented Gotcha4Life founders Gus Worland and Gareth Pike with this $450,000 gigantic novelty cheque at an event earlier this week.